BOTANIX PHARMACEUTICALS LTD(BOT.AU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

BOT.AU BOTANIX PHARMACEUTICALS LTD

未开盘 06-11 16:12:00 AEST

0.02

+0.00

+5.00%

最高0.02	最低0.02	成交量1,836万
今开0.02	昨收0.02	日振幅10.00%
总市值5,742万	流通市值3,607万	总股本27.34亿
成交额38.28万	换手率1.07%	流通股本17.18亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BOT.AU","market":"AU","secType":"STK","nameCN":"BOTANIX PHARMACEUTICALS LTD","latestPrice":0.021,"timestamp":1781158320000,"preClose":0.02,"halted":0,"volume":18358856,"delay":0,"changeRate":0.050000000000000044,"nameEN":"BOTANIX PHARMACEUTICALS LTD","floatShares":1717605114,"shares":2734312800,"eps":-0.046233,"marketStatus":"未开盘","change":0.001,"latestTime":"06-11 16:12:00 AEST","open":0.02,"high":0.022,"low":0.02,"amount":382798,"amplitude":0.1,"askPrice":0.022,"askSize":1705336,"bidPrice":0.021,"bidSize":202809,"shortable":3,"etf":0,"ttmEps":-0.046233,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1781222400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.02,"openAndCloseTimeList":[[1781136000000,1781157600000]],"volumeRatio":1.819687,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BOT.AU","preClose":0.02,"auctionPrice":0.021,"auctionVolume":817268,"auction":3,"marketStatus":"盘后竞价","timestamp":1781158192423}},"requestUrl":"/m/hq/s/BOT.AU/wiki","defaultTab":"wiki","newsList":[{"id":"1156030135","title":"皮拉马尔制药解决方案宣布与Botanix合作，支持药物原料开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1156030135","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156030135?lang=zh_cn&edition=full","pubTime":"2026-05-18 21:58","pubTimestamp":1779112695,"startTime":"0","endTime":"0","summary":"皮拉马尔制药有限公司旗下业务单元皮拉马尔制药解决方案宣布，已与Botanix Pharmaceuticals Ltd建立合作伙伴关系，旨在为其药物原料的开发工作提供支持。此项合作将整合双方的专业能力，共同推进相关药物开发项目的进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7502","BOT.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194932028","title":"Botanix制药与Piramal达成合作 后者将启动Sofdra活性成分溴化索夫溴铵的开发服务并担任替代商业供应商","url":"https://stock-news.laohu8.com/highlight/detail?id=1194932028","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194932028?lang=zh_cn&edition=full","pubTime":"2026-04-16 06:53","pubTimestamp":1776293594,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Limited  宣布与Piramal Pharma Solutions建立重要合作伙伴关系。根据协议，Piramal将正式启动溴化索夫溴铵的开发服务，该活性药物成分是Botanix旗下创新疗法Sofdra的核心成分。此次合作标志着Piramal将成为溴化索夫溴铵的替代商业供应商，为Botanix提供关键原料的供应链保障。作为专注于皮肤病创新疗法的研发企业，Botanix通过此次合作进一步优化了其供应链体系。双方案担的协同合作，将为Sofdra未来的市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOT.AU","BK7508","BK7502","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193258984","title":"Botanix制药公司获得4000万澳元两轮增发坚定承诺，新股发行价每股0.06澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193258984","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193258984?lang=zh_cn&edition=full","pubTime":"2026-02-17 06:44","pubTimestamp":1771281854,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Ltd（澳交所代码：BOT）宣布已成功获得总额4000万澳元的两轮增发坚定认购承诺。此次增发的新股定价为每股0.06澳元，标志着市场对该公司发展前景的强劲信心。\n这项融资计划将分两个阶段实施，旨在为公司的研发项目和运营扩张提供资金支持。每股0.06澳元的发行价反映了投资者对Botanix制药业务战略和增长潜力的认可。此次增发的顺利完成，预计将显著增强公司的资金实力，为其在制药领域的持续创新和市场拓展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOT.AU","BK7502","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.botanixpharma.com","stockEarnings":[{"period":"1week","weight":-0.0909},{"period":"1month","weight":-0.3548},{"period":"3month","weight":-0.6154},{"period":"6month","weight":-0.8261},{"period":"1year","weight":-0.9412},{"period":"ytd","weight":-0.8519}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.0206},{"period":"3month","weight":0.0263},{"period":"6month","weight":0.0162},{"period":"1year","weight":0.0903},{"period":"ytd","weight":-0.006}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052258},{"month":2,"riseRate":0.6,"avgChangeRate":0.054539},{"month":3,"riseRate":0.2,"avgChangeRate":0.005373},{"month":4,"riseRate":0.4,"avgChangeRate":0.017206},{"month":5,"riseRate":0.5,"avgChangeRate":0.047292},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07275},{"month":7,"riseRate":0.6,"avgChangeRate":0.023306},{"month":8,"riseRate":0.5,"avgChangeRate":0.048877},{"month":9,"riseRate":0.5,"avgChangeRate":-0.063468},{"month":10,"riseRate":0.4,"avgChangeRate":0.0297},{"month":11,"riseRate":0.4,"avgChangeRate":0.019363},{"month":12,"riseRate":0.6,"avgChangeRate":0.160698}],"exchange":"ASX","name":"BOTANIX PHARMACEUTICALS LTD","nameEN":"BOTANIX PHARMACEUTICALS LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BOTANIX PHARMACEUTICALS LTD(BOT.AU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BOTANIX PHARMACEUTICALS LTD(BOT.AU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BOTANIX PHARMACEUTICALS LTD,BOT.AU,BOTANIX PHARMACEUTICALS LTD股票,BOTANIX PHARMACEUTICALS LTD股票老虎,BOTANIX PHARMACEUTICALS LTD股票老虎国际,BOTANIX PHARMACEUTICALS LTD行情,BOTANIX PHARMACEUTICALS LTD股票行情,BOTANIX PHARMACEUTICALS LTD股价,BOTANIX PHARMACEUTICALS LTD股市,BOTANIX PHARMACEUTICALS LTD股票价格,BOTANIX PHARMACEUTICALS LTD股票交易,BOTANIX PHARMACEUTICALS LTD股票购买,BOTANIX PHARMACEUTICALS LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BOTANIX PHARMACEUTICALS LTD(BOT.AU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BOTANIX PHARMACEUTICALS LTD(BOT.AU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}